Antibodies to urinary tract pathogens in patients with spinal cord lesions

Spinal Cord

Volumn 36, Issue 9, 1998, Pages 613-616

  Moser, C ^a   Kriegbaum, N J ^a   Larsen, S O ^b   Hoiby N ^a   Biering Sorensen F ^a  

^a Rigshospitalet   (Denmark)

^b STATENS SERUM INSTITUT   (Denmark)

Author keywords

Paraplegia; Recurrent infections; Spina bifida; Spinal cord injuries; Tetraplegia; Urinary tract infections precipitating antibodies

Indexed keywords

BACTERIUM ANTIBODY; CREATININE;

ADULT; AGED; ARTICLE; BLADDER FUNCTION; CORRELATION FUNCTION; CREATININE BLOOD LEVEL; ENTEROCOCCUS FAECALIS; ESCHERICHIA; ESCHERICHIA COLI; FEMALE; HUMAN; INTRAVENOUS PYELOGRAPHY; KIDNEY SCINTISCANNING; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; RECURRENT INFECTION; SPINAL CORD INJURY; URINARY TRACT INFECTION; URINE CULTURE;

EID: 0031669603     PISSN: 13624393     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.sc.3100693     Document Type: Article

References (21)

1. Barton CH, Vaziri ND, Gordon S, Tilles S. Renal pathology in end-stage renal disease associated with paraplegia. Paraplegia 1984; 22: 31-41.
2. DeVivo MJ, Kartus PL, Rutt RD, Fine PR. Cause of death for patients with spinal cord injuries. Arch Intern Med 1989; 149: 1761-1766.
3. Hartkopp A, Brønnum-Hansen H, Seidenschnur A-M, Biering-Sørensen F. Survival and cause of death after traumatic spinal cord injury. Spinal Cord 1997; 35: 76-85.
4. Najenson T et al. Upper urinary tract in patients after traumatic spinal cord injury. Paraplegia 1969; 7: 85-96.
5. Viera A, Merrit JL, Erickson RP. Renal function in spinal cord injury: A Preliminary report. Arch Phys Med Rehabil 1986; 59: 257-259.
6. Erickson RP, Merrill JL, Opitz JL, Ilstrup DM. Bacteriuria during follow-up in patients with spinal cord injury: 1. Rates of bacteriuria in various bladder emptying methods. Arch Phys Med Rehabil 1982; 63: 409-412.
7. Kuhlemeier KV, Stover SL, Lloyd LK. Prophylactic antibacterial therapy for preventing urinary tract infections in spinal cord injury patients. J Urol 1985; 134: 514-517.
8. Pedersen SS, Horbov S, Biering-Sørensen F, Høiby N. Peroral treatment with ciprofloxacin of patients with spinal cord lesions and bacteriuria caused by multiply resistant bacteria. Paraplegia 1990; 28: 41-47.
9. Ruutu M, Lehtonen T. Urinary tract complications in spinal cord injury patients. Ann Chirugiae Gynaecologiae 1984; 73: 325-330.
10. Stover SL, Lloyd LK, Waites KB, Jackson AB. Urinary tract infection in spinal cord injury. Arch Phys Med Rehabil 1989; 70: 47-54.
11. Stover SL, Lloyd LK, Waites KB, Jackson AB. Neurogenic urinary tract infection. In: Young RR, Woolsey RM (eds). Diagnosis and Management of Disorder of the Spinal Cord. 1st edn. WB Saunders Company: Philadelphia, 1995, pp 198-210.
12. Høiby N, Koch C. Pseudomonas aeruginosa infection in cystic fibrosis and its management. Thorax 1990; 45: 881-884.
13. Høiby N, Döring G, Schiøtz PO. The role of immune complexes in the pathogenesis of bacterial infections. Ann Rev Microbiol 1986; 40: 29-53.
14. Høiby N. Pseudomonas aeruginosa infection in cystic fibrosis: Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by crossed immunoelectrophoresis. A survey. Acta Pathol Microbiol Scand 1977; Suppl 262 (C): 3-96.
15. Høiby N et al. Taxonomic applications of crossed immunoelectrophoresis. Internat J Syst Bact 1987; 37: 229-240.
16. Høiby N, Schiøtz PO. Immune complex mediated tissue damage in the lungs of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection. Acta Paediatr Scand 1982; Suppl 301: 63-73.
17. Høiby N. Antibodies against Pseudomonas aeruginosa in serum from normal persons and patients colonized with mucoid and non-mucoid Pseudomonas aeruginosa: results obtained by crossed immunoelectrophoresis. Acta Path Microbiol Scand 1977; Sect C 85: 142-148.
18. Høiby N. Microbiology of lung infections in cystic fibrosis patients. Acta Paediatr Scand 1982; Suppl 301: 33-54.
19. Høiby N, Hertz JB. Precipitating antibodies against Escherichia Coli, Bacteroides fragilis ss, thetaiotaomicron and Pseudomonas aeruginosa in serum from normal persons and cystic fibrosis patients, determined by means of crossed immunoelectrophoresis. Acta Paediatr Scand 1979; 68: 495-500.
20. Oderda G et al. Eighteen month follow up of Helicobacter pylori positive children treated with amoxycillin and tinidazole. Gut 1992; 33: 1328-1330.
21. Biering-Sørensen F et al. Ciprofloxacin as prophylaxis for urinary tract infection: Prospective, randomized, cross-over, placebo controlled study in patients with spinal cord lesion. J Urology 1994; 151: 105-108.